Senores Pharmaceuticals Limited (SENORES) reports a robust Q1 FY27 with revenue up 36% and EBITDA & PAT surging by 87% and 56% respectively.
Marksans Pharma Limited (MARKSANS) stock gains 6% intraday to ₹261.7, showing a bounce despite the 6M trendline status being in breakdown. Full details inside.
Piramal Pharma Limited (PPLPHARMA) stock breaks out, moving up 5% intraday to ₹191.61, clearing its 6-month resistance trendline.
Laurus Labs Limited (NSE: LAURUSLABS) stock price moves up 5% intraday to ₹1683.0, testing resistance in the Healthcare sector.
SAGILITY LIMITED (NSE: SAGILITY) stock price moves up 5% intraday, clearing its 6-month resistance trendline at ₹42.77.
Sudeep Pharma Limited (NSE: SUDEEPPHRM) edges up 5% intraday to ₹868.35, approaching support but not clearing 6M resistance. Healthcare sector focus.
Caplin Point Laboratories Limited (NSE: CAPLIPOINT) stock gains 5% intraday to ₹2601.2, showing a bounce despite a breakdown trendline status.
Dr. Lal Path Labs Ltd. (LALPATHLAB) cleared its 6M resistance trendline, gaining 5% intraday. The stock is now above resistance at ₹1738, showing a strong up.
Thyrocare Technologies Limited (NSE: THYROCARE) stock price moves up 5% intraday to ₹594.55, clearing its 6M resistance trendline..
Sakar Healthcare Limited (SAKAR) reports 38% YoY revenue growth in Q1FY27, with PAT rising 120%.